‘Decision to use Pfizer-BioNTech vaccine up to NPRA’


The Health Ministry’s National Pharmaceutical Regulatory Agency (NPRA) has received the clinical data on the Covid-19 vaccine from Pfizer-BioNTech, says Khairy Jamaluddin.

The Science, Technology and Innovations Minister said the decision to use the vaccine from the company lies with NPRA and the Health Ministry upon the completion of the registration and approval process.

Unlock 30% Savings on Ad-Free Access Now!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Others Also Read


Want to listen to full audio?

Unlock unlimited access to enjoy personalise features on the TheStar.com.my

Already a member? Log In